Proteins

Items 131-140 of 208

per page
Set Descending Direction
  1. IL-7 (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
    AG-40B-0247
    AG-40B-0247-C05050 µg
    CHF 440.00
    IL-7 (human) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
  2. IL-7 (human) (monomeric):Fc-KIH (human) (rec.)
    AG-40B-0238
    AG-40B-0238-C05050 µg
    CHF 440.00
    IL-7 (human) (monomeric):Fc-KIH (human) (rec.)
  3. IL-7 (mouse) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
    AG-40B-0256
    AG-40B-0256-C05050 µg
    CHF 440.00
    IL-7 (mouse) (monomeric):Fc (LALA-PG)-KIH (human) (rec.)
  4. Isthmin-1 (human) (rec.) (His)
    AG-40B-0214
    AG-40B-0214-C05050 µg
    CHF 360.00
    AG-40B-0214-30503 x 50 µg
    CHF 720.00
  5. Isthmin-1 (mouse) (rec.) (His)
    AG-40B-0215
    AG-40B-0215-C05050 µg
    CHF 330.00
    AG-40B-0215-30503 x 50 µg
    CHF 660.00
  6. Kynurenine Aminotransferase II (human) (rec.) (His)
    AG-40T-0102
    AG-40T-0102-C05050 µg
    CHF 590.00
  7. LAG-3 (human):Fc (human) (rec.)
    AG-40B-0031
    AG-40B-0031-C05050 µg
    CHF 395.00
    Binding of LAG-3 (human):Fc (human) (rec.) (Prod. No. AG-40B-0031) on dendritic and B cells. Method: Monocyte-derived immature DC (iDC), DC matured for 48h with LPS (mDC) and EBV-transformed B-cells are incubated with either an anti-
  8. LAG-3 (mouse):Fc (mouse) (rec.)
    AG-40B-0039
    AG-40B-0039-C05050 µg
    CHF 410.00
  9. LIF (human) (rec.)
    AG-40B-0093
    AG-40B-0093-C01010 µg
    CHF 170.00
    AG-40B-0093-30103 x 10 µg
    CHF 335.00
    AG-40B-0093-C100100 µg
    CHF 1'010.00
    Figure: Human Leukemia Inhibitory Factor (LIF) (rec.) (AG-40B-0093) maintains pluripotency of mouse ES cells. Method: Mouse ES oct4 GFP cells were cultured for 3 days in the presence of the indicated concentrations of LIF and followed
  10. LIGHT, Soluble (human) (rec.)
    AG-40B-0009
    AG-40B-0009-C01010 µg
    CHF 145.00
    AG-40B-0009-30103 x 10 µg
    CHF 290.00

Items 131-140 of 208

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.